TokensHive
Dashboard 🇪🇸

Polymarket Market

Prediction market

Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.

Upcoming
MarketLive pricing
Probability
30%
Liquidity
$7.4K
Best bid
1%
Best ask
99%
Spread
98%
Last trade
30%

Outcomes

Market outcomes

Yes 30% Current quote
No 30% Current quote

Live pricing

Pricing and liquidity

Current bid, ask, midpoint, spread, and market depth for this outcome.

Best bid
1%
Best ask
99%
Midpoint
50%
Spread
98%
Last trade
30%
Depth
4,917.64 / 2,484.79

Price history

Waiting for price history

History unavailable

Bids

PriceSize
1%2,115
2%1,000
3%11.39
6%600
10%300
18%200
20%286
26%134.61

Asks

PriceSize
99%2,115
98%100
97%13.06
95%27
73%30
72%47.28
71%55.3
70%5.15

Trades

Recent trades

Latest visible trades for this market.

  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 30% 5.66 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 71% 4.86 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 37% 30 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 62% 6.45 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 59% 25.42 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 33.1% 140 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 57% 7 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 57% 54 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 44% 8 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 40% 30 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    No 36.2% 151 shares
  • FDA approves GSK & Spero Therapeutics' Tebipenem HBr?
    Yes 68% 4.93 shares